Kidney Power

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

Lycium barbarum, Quantity: 125 mg (Equivalent: Lycium barbarum, Qty 500 mg); Epimedium sagittatum, Quantity: 40 mg (Equivalent: Epimedium sagittatum, Qty 800 mg); Ganoderma lucidum, Quantity: 5 mg (Equivalent: Ganoderma lucidum, Qty 50 mg); Cordyceps sinensis, Quantity: 5 mg (Equivalent: Cordyceps sinensis, Qty 100 mg); Rehmannia glutinosa, Quantity: 114.29 mg (Equivalent: Rehmannia glutinosa, Qty 800 mg); Wolfiporia cocos, Quantity: 60 mg (Equivalent: Wolfiporia cocos, Qty 300 mg); Cornus officinalis, Quantity: 80 mg (Equivalent: Cornus officinalis, Qty 400 mg); Alisma orientale, Quantity: 60 mg (Equivalent: Alisma orientale, Qty 300 mg); Cuscuta hygrophilae, Quantity: 71.43 mg (Equivalent: Cuscuta hygrophilae, Qty 500 mg); Dioscorea oppositifolia, Quantity: 80 mg (Equivalent: Dioscorea oppositifolia, Qty 400 mg)

Disponible depuis:

Concord International Trading Pty Ltd

DCI (Dénomination commune internationale):

Alisma orientale,Cordyceps sinensis,Cornus officinalis,Cuscuta hygrophilae,Dioscorea oppositifolia,Epimedium sagittatum,Ganoderm

forme pharmaceutique:

Tablet, uncoated

Composition:

Excipient Ingredients:

Mode d'administration:

Oral

indications thérapeutiques:

Traditionally used in Chinese medicine to enrich/nourish/tonify/fortify/strengthen kidneys ; Traditionally used in Chinese medicine to Helps enhance/promote/increase vitality ; Traditionally used in Chinese medicine to Helps enhance/promote general health and wellbeing ; Traditionally used in Chinese medicine to Maintain/support healthy sexual function

Descriptif du produit:

Visual Identification: ;

Statut de autorisation:

Licence status A

Date de l'autorisation:

2015-11-27